Type 2 Diabetes Mellitus Completed Phase 1 Trials for Imeglimin (DB12509)

Also known as: Non-Insulin-Dependent Diabetes Mellitus / Type 2 Diabetes Mellitus (T2DM) / Type 2 Diabetes / Diabetes, Type II / Type II Diabetes Mellitus / T2DM / Type Two Diabetes Mellitus / Diabetes mellitus non-insulin-dependent / NIDDM / Diabetes mellitus: [adult onset] or [noninsulin dependent] / Diabetes mellitus type 2 (disorder) / Diabetes mellitus: [adult onset, with no mention of complication] or [maturity onset] or [non-insulin dependent] / Diabetes Mellitus, Type 2 / Diabetes mellitus non insulin-dep / Maturity onset diabetes / Diabetes mellitus maturity onset

IndicationStatusPhase
DBCOND0029752 (Type 2 Diabetes Mellitus)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02373150Safety, Tolerability and PK of Imeglimin in Japanese VolunteersTreatment